Previous studies into the detection of EGFR mutations using plasma cfDNA have noted low sensitivity compared with tumor tissue biopsies with an average sensitivity of 65–70% and high specificity (> 88%) [20, 21]. The gene discussed is EGFR; the disease is neoplasm.